Gary Meyer

1.2k total citations
19 papers, 917 citations indexed

About

Gary Meyer is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Gary Meyer has authored 19 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Gary Meyer's work include Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Gary Meyer is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Gary Meyer collaborates with scholars based in United States, Germany and France. Gary Meyer's co-authors include Eva L. Feldman, Margit Burmeister, David Kapfhamer, María E. Díaz, Xiaoxi Qiao, Jeffrey L. Noebels, Shannon L. Carskadon, Andrew A. Peden, Margaret S. Robinson and Thomas A. Abrams and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Gary Meyer

18 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Meyer United States 9 403 309 165 164 92 19 917
Anas M. Alazami Saudi Arabia 22 857 2.1× 100 0.3× 118 0.7× 79 0.5× 129 1.4× 55 1.5k
Tzipora C. Falik‐Zaccai Israel 19 326 0.8× 136 0.4× 78 0.5× 116 0.7× 50 0.5× 56 809
Mohammed A. Aldahmesh Saudi Arabia 32 1.2k 3.0× 213 0.7× 135 0.8× 50 0.3× 37 0.4× 61 2.0k
Shannon L. Carskadon United States 10 492 1.2× 252 0.8× 67 0.4× 98 0.6× 137 1.5× 11 929
Hana M. Odeh United States 15 751 1.9× 119 0.4× 112 0.7× 136 0.8× 234 2.5× 20 1.8k
Pim Visser Netherlands 15 917 2.3× 135 0.4× 200 1.2× 120 0.7× 36 0.4× 18 1.4k
Philip B. Daniel United States 15 715 1.8× 79 0.3× 164 1.0× 118 0.7× 32 0.3× 29 1.5k
S.A. Whitmore Australia 18 536 1.3× 114 0.4× 58 0.4× 167 1.0× 39 0.4× 26 1.3k
Melanie K. Webster United States 15 1.4k 3.5× 184 0.6× 102 0.6× 224 1.4× 57 0.6× 18 1.8k
Stéphanie Cherqui United States 28 538 1.3× 220 0.7× 107 0.6× 66 0.4× 35 0.4× 56 2.3k

Countries citing papers authored by Gary Meyer

Since Specialization
Citations

This map shows the geographic impact of Gary Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Meyer more than expected).

Fields of papers citing papers by Gary Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Meyer. The network helps show where Gary Meyer may publish in the future.

Co-authorship network of co-authors of Gary Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Meyer. A scholar is included among the top collaborators of Gary Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Meyer. Gary Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Abrams, Thomas A., Gary Meyer, Lisa M. Hess, et al.. (2018). Patterns of chemotherapy (CT) use in a U.S.-wide cohort of patients (pts) with metastatic gastric cancer (MGC).. Journal of Clinical Oncology. 36(4_suppl). 112–112.
2.
Abrams, Thomas A., Gary Meyer, Jeffrey A. Meyerhardt, et al.. (2017). Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. The Oncologist. 22(8). 925–933. 38 indexed citations
3.
Lim, Kian‐Huat, Emma Langley, Feng Gao, et al.. (2017). A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma. Oncotarget. 8(15). 24250–24261. 5 indexed citations
4.
Abrams, Thomas A., Gary Meyer, Deborah Schrag, et al.. (2014). Chemotherapy Usage Patterns in a US-Wide Cohort of Patients With Metastatic Colorectal Cancer. JNCI Journal of the National Cancer Institute. 106(2). djt371–djt371. 82 indexed citations
5.
Abrams, Thomas A., Gary Meyer, Jeffrey A. Meyerhardt, et al.. (2014). Patterns of chemotherapy (CT) use in a population-based US-wide cohort of patients (pts) with metastatic pancreatic cancer (MPC).. Journal of Clinical Oncology. 32(15_suppl). 4131–4131. 6 indexed citations
6.
Abrams, Thomas A., et al.. (2012). Patterns of chemotherapy (CT) use in a U.S.-wide population-based cohort of patients (pts) with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 30(15_suppl). 3537–3537. 2 indexed citations
7.
Singh, Sharat, Gary Meyer, & Hua Gong. (2010). S1315 Identification of Novel Metabolites in Serum of Patients With Irritable Bowel Syndrome. Gastroenterology. 138(5). S–227. 1 indexed citations
8.
Meyer, Gary, Louis Chesler, Dandan Liu, et al.. (2007). Nordihydroguaiaretic acid inhibits insulin‐like growth factor signaling, growth, and survival in human neuroblastoma cells. Journal of Cellular Biochemistry. 102(6). 1529–1541. 34 indexed citations
9.
Meyer, Gary, et al.. (2005). Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility. Cellular and Molecular Life Sciences. 62(4). 461–470. 25 indexed citations
10.
Dervieux, Thierry, Joel M. Kremer, Gary Meyer, et al.. (2004). Contribution of common polymorphisms in reduced folate carrier and ??-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis. Pharmacogenetics. 14(11). 733–739. 138 indexed citations
11.
Meyer, Gary & Eva L. Feldman. (2002). Signaling mechanisms that regulate actin‐based motility processes in the nervous system. Journal of Neurochemistry. 83(3). 490–503. 151 indexed citations
12.
Meyer, Gary, et al.. (2001). Insulin-like growth factor I stimulates motility in human neuroblastoma cells. Oncogene. 20(51). 7542–7550. 53 indexed citations
13.
Puttagunta, Radhika, Laurie Gordon, Gary Meyer, et al.. (2000). Comparative Maps of Human 19p13.3 and Mouse Chromosome 10 Allow Identification of Sequences at Evolutionary Breakpoints. Genome Research. 10(9). 1369–1380. 29 indexed citations
14.
Qiao, Xiaoxi, María E. Díaz, Andrew A. Peden, et al.. (1998). Mutation in AP-3 δ in the mocha Mouse Links Endosomal Transport to Storage Deficiency in Platelets, Melanosomes, and Synaptic Vesicles. Neuron. 21(1). 111–122. 335 indexed citations
15.
Burmeister, Margit & Gary Meyer. (1997). The trefoil gene maps to mouse chromosome 17. Mammalian Genome. 8(3). 223–224. 7 indexed citations
16.
Meier, Werner & Gary Meyer. (1990). Paraaortales Spätrezidiv eines Dysgerminoms. Geburtshilfe und Frauenheilkunde. 50(5). 414–416. 1 indexed citations
17.
Fateh‐Moghadam, A., Andreas Pfeiffer, W. Samtleben, et al.. (1987). Long-term remission of immune neutropenia after treatment with high-dose intravenous 7S-immunoglobulin. Journal of Molecular Medicine. 65(20). 985–988. 1 indexed citations
18.
Serrou, B, H Sancho-Garnier, P Cappelaere, et al.. (1982). Follow-Up Results from a Randomized Trial for T3 and T4 Breast Cancer Patients: Previous BCG Immunotherapy Improves Response to Chemotherapy in the Relapse Patient. Recent results in cancer research. 80. 157–161. 1 indexed citations
19.
Serrou, B, H Sancho-Garnier, P Cappelaere, et al.. (1979). Results of a Randomized Trial of Prophylactic Chemotherapy in T3-T4 Breast Cancer Patients Previously Treated by Radiotherapy. Recent results in cancer research. 68. 105–108. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anas M. Alazami Breakdown of academic impact, for papers by Tzipora C. Falik‐Zaccai Breakdown of academic impact, for papers by Mohammed A. Aldahmesh Breakdown of academic impact, for papers by Shannon L. Carskadon Breakdown of academic impact, for papers by Hana M. Odeh Breakdown of academic impact, for papers by Pim Visser Breakdown of academic impact, for papers by Philip B. Daniel Breakdown of academic impact, for papers by S.A. Whitmore Breakdown of academic impact, for papers by Melanie K. Webster Breakdown of academic impact, for papers by Stéphanie Cherqui
Rankless by CCL
2026